将尿量加入血清肌酐测量用于大手术后急性肾损伤分期:一项队列研究的预后意义
该队列研究纳入2005年1月至2011年3月在加拿大卡尔加里接受大型非心脏手术的成人(无终末期肾病),共4229例(17%)有足够血清肌酐和尿量测量。将尿量加入血清肌酐标准后,术后急性肾损伤的表观发生率从8.1%升至64.0%,但同一分期的死亡率降低;在血清肌酐标准无急性肾损伤者中,尿量越低死亡比值比和平均住院时间均显著增加。结论认为尿量与血清肌酐标准不应视为急性肾损伤分期的等效标准。
要点
- 将尿量加入血清肌酐标准后,术后急性肾损伤表观发生率由8.1%升至64.0%。
- 同一急性肾损伤分期下,加入尿量标准后的死亡率低于单用血清肌酐标准。
- 血清肌酐标准无急性肾损伤者中,尿量越低死亡比值比和平均住院时间显著增加。
核心结论
- 将尿量加入血清肌酐标准会大幅增加病房急性肾损伤的表观发生率,并显著改变急性肾损伤识别与分期的预后意义。
- 作者认为尿量与血清肌酐标准在急性肾损伤分期中不应被视为等效标准。
研究设计与样本
- 研究为队列研究,纳入2005年1月至2011年3月在加拿大卡尔加里接受大型非心脏手术、无终末期肾病的成人。
- 参与者需至少两次血清肌酐和尿量测量方可纳入,共4229例(17%)手术患者符合条件。
- 依据改善全球肾脏病预后组织标准进行急性肾损伤分期,采用逻辑回归和线性回归模型分析急性肾损伤分期与30天死亡率或住院时间的关联。
主要发现
- 术后急性肾损伤表观发生率单用血清肌酐标准为8.1%,联合血清肌酐和尿量标准为64.0%。
- 加入尿量标准后,无急性肾损伤及1、2、3期的死亡率分别为0.3%、3.2%、1.9%和3.0%;单用血清肌酐标准时分别为1.2%、4.2%、15.4%和12.8%。
- 在血清肌酐标准无急性肾损伤的参与者中,尿量越低,死亡比值比和平均住院时间均显著增加。
- 在血清肌酐标准基础上根据尿量重新分类急性肾损伤分期的模型,对死亡率和住院时间的区分度最佳。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current guidelines recommend staging acute kidney injury (AKI) according to the serum creatinine (SCr) or urine output (UO) criteria that achieve the highest stage. There is little information about the implications of adding UO to SCr measurements for staging AKI outside intensive care units and after cardiac surgery. METHODS: We performed a cohort study of all adults without end-stage renal disease who underwent major noncardiac surgery between January 2005 and March 2011 in Calgary, AB, Canada. Participants required at least two SCr and UO measurements to be included. We examined the implications of adding UO to SCr to stage AKI based on Kidney Disease: Improving Global Outcomes criteria. Logistic and linear regression models were used to examine the associations between AKI stage and 30-day mortality or hospital length of stay (LOS), respectively. RESULTS: A total of 4229 (17%) surgical patients had sufficient SCr and UO measurements for inclusion in the cohort. The apparent incidence of postoperative AKI substantially increased with the addition of UO to SCr criteria (8.1% with SCr alone versus 64.0% with SCr and UO). Mortality for a given stage of AKI was lower when UO was added to SCr criteria (0.3, 3.2, 1.9 and 3.0% for no AKI and Stages 1, 2 and 3, respectively) versus with SCr alone (1.2, 4.2, 15.4 and 12.8%). However, among participants without AKI based on the SCr criterion, the odds of mortality and mean LOS both significantly increased with lower UO. Models that reclassified AKI stage based on UO in addition SCr criteria had the best discrimination for mortality and LOS. CONCLUSIONS: Adding UO to SCr criteria substantially increases the apparent incidence of AKI on hospital wards and significantly changes the prognostic implications of AKI identification and staging. These measures should not be considered equivalent criteria in AKI staging.
引用
- Quan S, Pannu N, Wilson T, et al. Prognostic implications of adding urine output to serum creatinine measurements for staging of acute kidney injury after major surgery: a cohort study. Nephrol Dial Transplant. 2016. PMID: 27941063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。